Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results
Go back to Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results| (NASDAQ: KRYS) | Delayed: 365.74 +1.90 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $363.84 | 52 Week High | $ | |||
| Open | $366.00 | 52 Week Low | $ | |||
| Day High | $373.19 | P/E | N/A | |||
| Day Low | $360.86 | EPS | $ | |||
| Volume | 119,495 | |||||

